NCT06322771Completed
Women's Refusal to Participate in a Randomized Trial Involving First-trimester Screening for Pre-eclampsia: Factors Associated With Refusal and Reasons for Acceptance and Refusal
Source: ClinicalTrials.gov · Last updated 15 Sept 2025
Brief summary (registry, in English)
The main objective is to assess whether there are factors associated with women's refusal to participate in a randomized clinical trial involving first-trimester screening for pre-eclampsia. The secondary objective is to qualitatively evaluate the reasons for acceptance and refusal to participate.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 472 (actual)
- First submitted
- 14 Mar 2024
- Start date
- 11 Apr 2024
- Primary completion date
- 31 Oct 2024
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- NCT number
- NCT06322771
What you commit to
- Study type: Observational
- Participants enrolled: 472
- From 11 Apr 2024 to the primary completion date, 31 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Any pregnant woman is eligible if:
- monofetal pregnancy
- between 11 and 14 weeks
- legal age
- health insurance coverage
Age in the registry: 18 years to - · Sex: Female
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Port-Royal Maternity Coordinator of this site? Confirm its status | Paris | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.